Acumen Pharmaceuticals, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 1210-1220 WASHINGTON STREET, NEWTON, MA, 02465
Mailing Address 1210-1220 WASHINGTON STREET, NEWTON, MA, 02465
Phone 617-344-4190
Fiscal Year End 1231
EIN 364108129
Financial Overview
FY2024
$310.13M
Total Assets
$57.18M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
Insider Trading
STRONG SELL 7 insiders
42 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.